Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo
AbstractThe functional inactivation of TP53 and Rb tumor suppressor proteins by the HPV-derived E6 and E7 oncoproteins is likely an important step in cervical carcinogenesis. We have previously shown siRNA technology to selectively silence both E6/E7 oncogenes and demonstrated that the synthetic siRNAs could specifically block its expression in HPV-positive cervical cancer cells. Herein, we investigated the potentiality of E6/E7 siRNA candidates as radiosensitizers of radiotherapy for the human cervical carcinomas. HeLa and SiHa cells were transfected with HPV E6/E7 siRNA; the combined cytotoxic effect of E6/E7 siRNA and radiation was assessed by using the cell viability assay, flow cytometric analysis and the senescence-associated β-galactosidase (SA-β-Gal) assay. In addition, we also investigated the effect of combined therapy with irradiation and E6/E7 siRNA intravenous injection in an in vivo xenograft model. Combination therapy with siRNA and irradiation efficiently retarded tumor growth in established tumors of human cervical cancer cell xenografted mice. In addition, the chemically-modified HPV16 and 18 E6/E7 pooled siRNA in combination with irradiation strongly inhibited the growth of cervical cancer cells. Our results indicated that simultaneous inhibition of HPV E6/E7 oncogene expression with radiotherapy can promote potent antitumor activity and radiosensitizing activity in human cervical carcinomas. View Full-Text
- Supplementary File 1:
Supplementary Information (PDF, 2280 KB)
Share & Cite This Article
Jung, H.S.; Rajasekaran, N.; Song, S.Y.; Kim, Y.D.; Hong, S.; Choi, H.J.; Kim, Y.S.; Choi, J.-S.; Choi, Y.-L.; Shin, Y.K. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo. Int. J. Mol. Sci. 2015, 16, 12243-12260.
Jung HS, Rajasekaran N, Song SY, Kim YD, Hong S, Choi HJ, Kim YS, Choi J-S, Choi Y-L, Shin YK. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo. International Journal of Molecular Sciences. 2015; 16(6):12243-12260.Chicago/Turabian Style
Jung, Hun S.; Rajasekaran, Nirmal; Song, Sang Y.; Kim, Young D.; Hong, Sungyoul; Choi, Hyuck J.; Kim, Young S.; Choi, Jong-Sun; Choi, Yoon-La; Shin, Young K. 2015. "Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo." Int. J. Mol. Sci. 16, no. 6: 12243-12260.